chlorhexidine rinse

PreclinicalSmall molecule

UUniversidade Estadual Paulista Júlio de Mesquita Filho

chlorhexidine rinse is one of 37 small molecule programs targeting Gingival Recession. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Gingival RecessionUnknown status

AgeCompleted

Gingival RecessionPreclinical

Unknown status

AgePreclinical

Completed

Competition

Competitive Landscape

49 competitors in Age

#DrugCompanyPhaseTrials

Actigall

AbbVie

Approved

—2

Rapamune

PPrism Pharmaceuticals

Approved

—3

Decadron

AAspen Global Incorporated

Phase 2

3 4

Sarclisa

AAzienda U.S.L. 1 di Massa e Carrara

Phase 2

1 5

Rezurock

KKadmon, a Sanofi Company

Phase 2

1 6

Venclexta

AbbVie

Phase 1

3 7

Acotiamide

GGetz Pharma

Phase 3

1 8

Evorpacept

AALX Oncology Inc.

Phase 2

1 9

APG-115

Ascentage Pharma Group Inc.

Phase 2

1 10

APG-2575

Ascentage Pharma Group Inc.

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Gingival Recession2 trials

Biofunctionalization of a Volume-stable Collagen Matrix (VCMX) for the Treatment of Single Gingival Recession

Unknown status·UUniversidade Estadual Paulista Júlio de Mesquita Filho·N/A·NCT05916742·75 enrolled

Mucoderm® Versus CTG in the Treatment of Multiple Gingival Recessions Associated With Non-carious Cervical Lesion.

Unknown status·UUniversidade Estadual Paulista Júlio de Mesquita Filho·N/A·NCT03594513·50 enrolled

Clinical Trial1 trial

"Clinical Trials to Enhance Elders' Oral Health" ("TEETH")

Completed·UUniversity of Washington·Phase 3·NCT00004640·1,101 enrolled

Age1 trial

Comparison of Two Flaps for Root Coverage

Completed·UUniversidade Estadual Paulista Júlio de Mesquita Filho·N/A·NCT02814279·42 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for chlorhexidine rinse. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — chlorhexidine rinse compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for chlorhexidine rinse. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Universidade Estadual Paulista Júlio de Mesquita Filho company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversidade Estadual Paulista Júlio de Mesquita Filho

chlorhexidine rinse

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Gingival Recession2 trials

Clinical Trial1 trial

Age1 trial

References

Drug Info

Quick Facts

Related News